E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/10/2017 in the Prospect News Structured Products Daily.

New Issue: Credit Suisse sells $4 million contingent coupon autocallable yield notes on ETFs

By Wendy Van Sickle

Columbus, Ohio, July 10 – Credit Suisse AG, London Branch priced $4 million of contingent coupon autocallable yield notes due June 28, 2019 linked to the lesser performing of the SPDR S&P Biotech exchange-traded fund and the SPDR S&P Regional Banking exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a quarterly contingent coupon at an annual rate of 11.4% if each fund closes at or above its coupon barrier, 70% of its initial level, on the observation date for that quarter.

The notes will be called at par if each fund closes at or above its initial level on any quarterly call observation date.

The payout at maturity will be par unless either fund finishes below its initial level and either fund finishes below its 70% knock-in level, in which case investors will be fully exposed to any losses of the worse performing fund.

Credit Suisse Securities (USA) LLC is the agent.

Issuer:Credit Suisse AG, London Branch
Issue:Contingent coupon autocallable yield notes
Underlying funds:SPDR S&P Biotech ETF and SPDR S&P Regional Banking ETF
Amount:$4 million
Maturity:June 28, 2019
Coupon:11.4% per year, payable quarterly if each fund closes at or above its barrier level on quarterly observation date
Price:Par
Payout at maturity:Par plus unless either fund finishes below knock-in level, in which full exposure to the losses of the worst-performing fund
Call:Automatically if each fund closes at or above its initial level on any quarterly call observation date beginning on July 31
Initial prices:$77.27 for Biotech, $53.56 for Banking
Barrier/knock-in prices:$54.089 for Biotech, $37.492 for Banking; 70% of initial levels
Pricing date:June 27
Settlement date:June 30
Agent:Credit Suisse Securities (USA) LLC
Fees:2.35%
Cusip:22550BC27

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.